Experimental drug hoped to be the first to significantly slow decline of Alzheimer’s patients

A large trial has shown an experimental Alzheimer’s drug developed by Eisai Co Ltd and Biogen Inc to have significantly slowed decline of patients in the early stages of the disease…
Read More